Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 1186 AL 1200

[Vascular cognitive impairment]

Boss HM, van den Berg-Vos RM, Scheltens P, Weinstein HC.

Ned Tijdschr Geneeskd. 2010;154:A1907.

[A consideration for the mechanism of the transition from depression to dementia]

Baba H.

Seishin Shinkeigaku Zasshi. 2010;112(10):1003-8.

Appropriateness of using a symbol to identify dementia and/or delirium

Hines S, Abbey J, Wilson J, Sacre S.

Int J Evid Based Healthc. 2010 Sep;8(3):126-8. doi: 10.1111/j.1744-1609.2010.00169.x.

Interleukin-6 gene (-174 C/G ) and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population

Klimkowicz-Mrowiec A, Wołkow P, Spisak K, Maruszak A, Styczyńska M, Barcikowska M, Szczudlik A, Słowik A.

Neurol Neurochir Pol. 2010 Nov-Dec;44(6):537-41. doi: 10.1016/s0028-3843(14)60149-3.

Interethnic differences in dementia epidemiology: global and Asia-Pacific perspectives

Venketasubramanian N, Sahadevan S, Kua EH, Chen CP, Ng TP.

Dement Geriatr Cogn Disord. 2010;30(6):492-8. doi: 10.1159/000321675. Epub 2011 Jan 20.

Optimizing mild cognitive impairment for discriminating dementia risk in the general older population

Stephan BC, Savva GM, Brayne C, Bond J, McKeith IG, Matthews FE; Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Am J Geriatr Psychiatry. 2010 Aug;18(8):662-73. doi: 10.1097/jgp.0b013e3181e0450d.

Preventing Alzheimer's disease and cognitive decline

Williams JW, Plassman BL, Burke J, Benjamin S.

Evid Rep Technol Assess (Full Rep). 2010 Apr;(193):1-727.

[Language disorders in ALS/FTLD]

Ichikawa H.

Rinsho Shinkeigaku. 2010 Nov;50(11):1014-6. doi: 10.5692/clinicalneurol.50.1014.

Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain

Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB; MRC Cognitive Function and Ageing Neuropathology Study Group.

Neurobiol Aging. 2010 Apr;31(4):578-90. doi: 10.1016/j.neurobiolaging.2008.05.015. Epub 2008 Jun 30.

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Bürger K, Hampel H, Frölich L, Wolf S, Prinz B, Jahn H, Luckhaus Ch, Perneczky R, Hüll M, Schröder J, Kessler H, Pantel J, Gertz HJ, Klafki HW, Kölsch H, Reulbach U, Esselmann H, Maler JM, Bibl M, Kornhuber J, Wiltfang J.

Mol Psychiatry. 2010 Feb;15(2):138-45. doi: 10.1038/mp.2008.84. Epub 2008 Jul 29.

Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

Kester MI, Verwey NA, van Elk EJ, Scheltens P, Blankenstein MA.

Neurobiol Aging. 2010 Apr;31(4):539-40; author reply 541. doi: 10.1016/j.neurobiolaging.2008.07.024. Epub 2008 Oct 28.

Epigenetic changes in Alzheimer's disease: decrements in DNA methylation

Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J.

Neurobiol Aging. 2010 Dec;31(12):2025-37. doi: 10.1016/j.neurobiolaging.2008.12.005. Epub 2008 Dec 30.

Added diagnostic value of CSF biomarkers in differential dementia diagnosis

Le Bastard N, Martin JJ, Vanmechelen E, Vanderstichele H, De Deyn PP, Engelborghs S.

Neurobiol Aging. 2010 Nov;31(11):1867-76. doi: 10.1016/j.neurobiolaging.2008.10.017. Epub 2009 Jan 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias